InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,394.00
(
0.37%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
74.32
(
0.79%
)
Bitcoin
63,747.59
(
0.66%
)
Post# of 253199
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biocqr

Send PM Follow Ignore
Followers 49
Posts 3520
Boards Moderated 0
Alias Born 08/24/2005

biocqr

Member Level

Re: ronpopeil post# 237258

Saturday, 02/27/2021 2:18:30 PM

Saturday, February 27, 2021 2:18:30 PM

Post# of 253199

I will then have less shares as it equates to the new valuation?


You will have the same number of shares. The valuation is negotiated between the SPAC and Humacyte. According to this MF article Humacyte is being valued at $1.1B and AHAC is investing $100M so after accounting for the SPAC founder's shares, the public holders of AHAC should collectively own about 7% of Humacyte.

The ticker will change to HUMA after the close.

Regenerative Tissue Developer Humacyte Going Public Via SPAC
https://www.fool.com/investing/2021/02/17/regenerative-tissue-developer-humacyte-going-publi/


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up